Sort
50,496 grants matching “lung cancer”
Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy
$442,325Roman Perez-Soler · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · CA
Clinical Diagnostic Studies and Treatment of Patients with Immune Deficiencies
$442,270Suk De Ravin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Surgical and Animal Core
$442,242Dai Fukumura · Massachusetts General Hospital · P01 · FY2015 · CA
Platelet Serine/Threonine Phosphatases in Cancer Pathophysiology
$442,222K. Vinod Vijayan · Baylor College Of Medicine · R01 · FY2021 · CA
(PQ10) The impact of the gut microbiome on the anti-tumor effects of radiotherapy
$442,221Andrea Facciabene · University Of Pennsylvania · R01 · FY2021 · CA
Genetic basis of chemotherapy-induced neuropathy in a reduced complexity cross
$442,176Mohamad Imad Damaj · Virginia Commonwealth University · R01 · FY2018 · CA
Targeting NSD1 in leukemia
$442,141Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Genetic dissection of oncogenic RAS-driven tumor initiation in vivo
$442,103Christopher M Counter · Duke University · R01 · FY2025 · CA
Regulatory Pathways Compromised by PRMT5 Inhibition in Cancers with MTAP Loss
$442,089Frederick H Wilson · Yale University · R37 · FY2025 · CA
PROMISE Trial: Substudy to Assess for Effective Dose of Radiation
$442,071Andrew Einstein · Columbia University Health Sciences · R01 · FY2014 · HL
Multidisciplinary research training in pulmonary diseases
$442,058Claire M Doerschuk · Univ Of North Carolina Chapel Hill · T32 · FY2016 · HL
BWS and Embryonal Tumor Suppressor Genes on 11p15
$442,020Andrew P Feinberg · Johns Hopkins University · R37 · FY2009 · CA
Tumor-targeted inhibitors of stearoyl-CoA desaturase for the treatment of cancer.
$442,017Deepak Nijhawan · Ut Southwestern Medical Center · R01 · FY2022 · CA
Palliative Care: Maximizing Patient Preference
$441,993Donald H Taylor · Duke University · R01 · FY2012 · HS
Investigating CREBBP as a tumor suppressor in small cell lung cancer
$441,962David Macpherson · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA
Investigating CREBBP as a tumor suppressor in small cell lung cancer
$441,962David Macpherson · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Investigating CREBBP as a tumor suppressor in small cell lung cancer
$441,962David Macpherson · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Investigating CREBBP as a tumor suppressor in small cell lung cancer
$441,962David Macpherson · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA
Targeting NSD1 in leukemia
$441,957Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$441,940Murray Korc · Indiana University Indianapolis · R01 · FY2016 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$441,940Murray Korc · Indiana University Indianapolis · R01 · FY2014 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$441,940Murray Korc · Indiana University Indianapolis · R01 · FY2017 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$441,940Murray Korc · Indiana University Indianapolis · R01 · FY2015 · CA
Identifying the pro-metastatic mechanisms of neutrophil extracellular traps
$441,891Mikala Egeblad · Johns Hopkins University · R01 · FY2024 · CA
NETS in thrombosis and inflammatory responses
$441,875Denisa D Wagner · Boston Children'S Hospital · R01 · FY2015 · HL